![]() There is a process at Fishawack Health for our scientific content, so it’s also a matter of making sure things are moving along timelines to ensure the client receives the deliverable on time.Īnother element of my job is management and training, for example, briefing and coaching more junior writers. Then I have internal meetings with our team to align on workflow and timelines and develop a plan to roll out the work. Often, I’ll meet with clients to get feedback, explore insights, and kick off new projects. Sometimes I’ll work on a more strategic piece of work, such as publication planning, which gives me the opportunity to solve new problems, and dive into new therapy areas and new science. I review medical content created by the team and develop content myself. There’s a real mix of diving into the science of a therapeutic area and collaboration with clients and the wider team. I’m lucky enough to have a role that combines my prior career in a different industry while also allowing me to think strategically and take on a people-facing role. I love writing – so it was a natural fit. I could leverage my training in veterinary medicine and science while also utilizing my medical language skills. I did a little research, and the job appealed to me right away. ![]() In the end, a friend suggested I look into medical communications – I had no idea what it was despite being in academia for years. I knew I wanted to combine my clinical and scientific training with my writing experience and needed to think outside the box. After that, I decided it was time for a career change. I had joined a small pharma startup that folded, as they often do. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.Why did you want to become a Medical Writer?īefore joining Fishawack Health, I had a career in academia as a veterinary clinician and bench-top scientist. The company assumes no duty to update the information to reflect subsequent developments. The information contained in this website was current as of the date presented. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (No Duty to Update The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Risks and uncertainties include, but are not limited to, general industry conditions and competition general economic factors, including interest rate and currency exchange rate fluctuations the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally global trends toward healthcare cost containment technological advances, new products and patents attained by competitors challenges inherent in new product development, including obtaining regulatory approval the company’s ability to accurately predict future market conditions manufacturing difficulties or delays financial instability of international economies and sovereign risk dependence on the effectiveness of the company’s patents and other protections for innovative products and the exposure to litigation, including patent litigation, and/or regulatory actions. ![]() If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. This website of Merck & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Worldwide Countries outside of the United States and Canada.įorward-Looking Statement Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA. ![]() We are known as Merck & Co., Inc., Rahway, New Jersey, USA in the United States, Canada & Puerto Rico. We are one company, but we operate under two different corporate brand names.
0 Comments
Leave a Reply. |